Ann Baker and John Cole are speaking on this topic. This webinar will examine the motivations for collaboration between biopharma and academia – two different worlds. Crucially, we will also reflect on why the outcomes of such collaborations often disappoint and consider some of the interventions that both parties can make to ensure a successful outcome. We will look at how to bridge the gap between academia and biopharma.
For more information on this event, click here.
A landscape assessment of newborn screening in Europe
Newborn screening (NBS), or the process of identifying members of a population who may have, or may be at risk of developing, a specific disease or condition,...